Extramedullary disease is associated with severe toxicities following B-cell maturation antigen CAR T-cell therapy in multiple myeloma
Extramedullary disease (EMD) in multiple myeloma (MM) is associated with poor outcomes following B-cell maturation antigen (BCMA)-targeted CAR-T therapy, yet its impact on treatment-related toxicity remains unclear. This study evaluates the impact of active EMD on toxicity, efficacy, and survival i...
Saved in:
| Main Authors: | Andrew J. Portuguese, Emily C. Liang, Jennifer J. Huang, Yein Jeon, Danai Dima, Rahul Banerjee, Mary Kwok, Kara I. Cicero, Alexandre V. Hirayama, Ryan Basom, Christy Khouderchah, Mazyar Shadman, Lawrence Fong, Andrew J. Cowan, Jordan Gauthier |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-06-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/12122 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Illuminating the Shadows: Innovation in Advanced Imaging Techniques for Myeloma Precursor Conditions
by: Kara I. Cicero, et al.
Published: (2025-01-01) -
Extramedullary CNS myeloma
by: Alessandro Gozzetti
Published: (2025-06-01) -
Extramedullary Multiple Myeloma: Challenges and Opportunities
by: Matthew Ho, et al.
Published: (2025-03-01) -
Real-world comparison of lisocabtagene maraleucel and axicabtagene ciloleucel in large B-cell lymphoma: an inverse probability of treatment weighting analysis with 3-year follow up
by: Andrew J. Portuguese, et al.
Published: (2025-03-01) -
Multiple myeloma with extramedullary plasmacytoma: pathogenesis and clinical case
by: M. V. Firsova, et al.
Published: (2022-11-01)